Dana J. Lukin, M.D., Ph.D.
Dr. Dana Lukin specializes in the care of patients with inflammatory bowel disease (IBD), including Crohn’s disease and ulcerative colitis. Dr. Lukin works closely with colleagues in affiliated specialties in order to provide comprehensive care for IBD patients within the Einstein-Montefiore Program for Inflammatory Bowel Diseases. He is involved in clinical trials, clinical and translational research in IBD, and serves on the Chapter Medical Advisory Committee (CMAC) for the New York Chapter of the Crohn’s and Colitis Foundation of America (CCFA).
Lukin DJ, Carvajal LA, Liu WJ, Resnick-Silverman L, Manfredi JJ. p53 Promotes cell survival due to the reversibility of its cell-cycle checkpoints. Mol Cancer Res. 2015 Jan;13(1):16-28. doi: 10.1158/1541-7786.MCR-14-0177. Epub 2014 Aug 26. PMID: 25158956
Lukin DJ and Swaminath AC. Case Report: Laryngeal Retention of a Video Capsule. Vis. Hum. J. Endoscopy. Volume 13, No. 1 (2014)
Westphalen CB, Asfaha S, Hayakawa Y, Takemoto Y, Lukin DJ, Nuber AH, Brandtner A, Setlik W, Remotti H, Muley A, Chen X, May R, Houchen CW, Fox JG, Gershon MD, Quante M, Wang TC. Long-lived intestinal tuft cells serve as colon cancer-initiating cells. J Clin Invest. 2014 Mar;124(3):1283-95. PMID: 24487592
Hamard PJ, Lukin DJ, Manfredi JJ. p53 basic C terminus regulates p53 functions through DNA binding modulation of subset of target genes. J Biol Chem. 2012 Jun 22;287(26):22397-407. doi: 10.1074/jbc.M111.331298. Epub 2012 Apr 18. PMID: 22514277
Lukin DJ, Jandorf LH, Dhulkifl RJ, Thélémaque LD, Christie JA, Itzkowitz SH, Duhamel KN. Effect of comorbid conditions on adherence to colorectal cancer screening. J Cancer Educ. 2012 Jun;27(2):269-76. doi: 10.1007/s13187-011-0303-2. PMID: 22351374
More Information About Dr. Dana Lukin
Montefiore Medical Center Profile
Material in this section is provided by individual faculty members who are solely responsible for its accuracy and content.